고혈압 복합제 복용환자에서 동일계열약물 중복 현황
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구현지 | - |
dc.contributor.author | 이지원 | - |
dc.contributor.author | 최하은 | - |
dc.contributor.author | 제남경 | - |
dc.contributor.author | 정경혜 | - |
dc.date.accessioned | 2023-02-19T16:41:56Z | - |
dc.date.available | 2023-02-19T16:41:56Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.issn | 2508-786X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/60740 | - |
dc.description.abstract | Background: Fixed-dose combinations have the advantage of improving patient compliance, but may increase the risk of duplicateprescriptions. As the use of fixed-dose combination antihypertensives increases, it is necessary to investigate the current status ofclass duplication prescriptions (CDP) in patients taking fixed-dose combination antihypertensives in Korea and to identify factorsassociated with CDP. Methods: We conducted a retrospective observational study using nationally representative claim data. Hypertensive patients aged 20 years or older taking fixed-dose combination antihypertensives were extracted. Among these patients,patients with CDP were identified. A chi-square test was applied to determine the differences between patients with CDP and non-CDP. The associated factors of CDP were identified through multiple logistic regression. Results: Of the 74,165 patients who wereprescribed fixed-dose combination antihypertensives, 426 patients (0.6%) with CDP were identified. The most commonantihypertensive class associated with CDP was calcium channel blockers (194 patients, 45.5%), followed by angiotensin II receptorblockers (136 patients, 31.9%). Patients aged 75 years or older (odds ratio [OR] 1.83, 95% confidence interval [CI] 1.02-3.52),chronic kidney disease (OR 4.45, 95% CI 2.15-8.25), chronic heart failure (OR 2.71, 95% CI 1.93-3.72), coronary artery disease(OR 2.22, 95% CI 1.60-3.03) and Medical Aid/Patriots and Veterans Insurance (OR 1.49, 95% CI 1.04-2.07) were significantlyassociated with increased CDP. Conclusions: The factors associated with CDP were the elderly, comorbidities, and lowsocioeconomic status. Since CDP can result in negative clinical outcomes, active intervention by the pharmacist is warranted. | - |
dc.format.extent | 8 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 한국임상약학회 | - |
dc.title | 고혈압 복합제 복용환자에서 동일계열약물 중복 현황 | - |
dc.title.alternative | Class duplication prescriptions in patients taking fixed-dose combination antihypertensives | - |
dc.type | Article | - |
dc.identifier.doi | 10.24304/kjcp.2022.32.1.125 | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.32, no.2, pp 125 - 132 | - |
dc.identifier.kciid | ART002852582 | - |
dc.description.isOpenAccess | Y | - |
dc.citation.endPage | 132 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 125 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 32 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Fixed-dose combination antihypertensives | - |
dc.subject.keywordAuthor | class duplication prescriptions | - |
dc.subject.keywordAuthor | calcium channel blockers | - |
dc.subject.keywordAuthor | angiotensin II receptor blockers | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.